Abstract
INTRODUCTION
Graft choice is a critical element for long-term patency and survival in coronary artery bypass grafting surgery (CABG) [1] [2] [3] [4] [5] [6] [7] . The left internal mammary artery (LIMA) has a greater long-term patency compared to the saphenous vein and significantly improves the long-term patient outcome when it is anastomosed to the left anterior descending artery (LAD) [2] . However, in some cases, the LIMA pedicle can be too short to reach the target lesion due to technical issues, or it can be accidentally damaged during its harvesting, or may not have adequate flow due to a stenosis of the subclavian artery. Despite this, when the technical problem is limited to the proximal part of the LIMA or its length, the arterial conduit can potentially be used on the LAD as a free graft. In support of this surgical option, the right internal mammary artery (RIMA) has shown excellent long-term patency and survival rates when used as a free graft on both the right and the left coronary artery systems [4, [8] [9] [10] . Moreover, the IMA used as a free graft functions in the same way as a pedicled graft, with comparable endothelial-dependent and endothelial-independent vasodilatory mechanisms [11] . The aim of the study was to evaluate our experience with the free IMA (f-IMA) on the LAD, in order to determine if there is an early and long-term outcome disadvantage in terms of survival, hospital readmission, and repeat coronary revascularization associated with this surgical strategy compared to the in situ IMA (is-IMA).
MATERIALS AND METHODS

Study population
Preoperative, intraoperative and postoperative data were obtained from the computerized cardiac surgical database that collects information prospectively for all adult patients undergoing cardiac †Presented at the 30th Annual Meeting of the European Association for Cardio-Thoracic Surgery, Barcelona, Spain, 1-5 October 2016. surgery at the Quebec Heart and Lung University Institute, Quebec City, Canada. Between 1991 and 2014, 21 876 consecutive patients underwent primary isolated CABG. Among these patients, 238 underwent an f-IMA graft to bypass the LAD. Off-pump and onpump beating heart surgeries, and cases of CABG with other associated procedures were excluded. For the purposes of this study, we included all patients who received IMA grafts, either right or left, exclusively to the LAD. Early and long-term outcomes including survival, hospital readmission for cardiovascular causes and repeat coronary revascularization up to a maximum of 23 years post-CABG were compared. Provincial vital statistics and administrative hospital readmission data were used to analyse long-term outcomes. All province-wide rehospitalizations at our institution and others due to cardiovascular reasons were captured in our longitudinal analysis, as the provincial government is the sole health insurance provider for advanced tertiary care cardiology and cardiac surgery. Cardiovascular causes for readmission included cardiac aetiologies: stable and unstable angina, myocardial infarction, cardiac arrest, ventricular dysrhythmia and heart failure; vascular aetiologies comprised transient ischaemic attack or stroke, intracerebral haemorrhage and peripheral vascular events. Repeat coronary revascularization was defined as any case of percutaneous coronary intervention or redo CABG. The first readmission due to a cardiovascular cause or procedure was the event of interest and repeated readmissions were not considered. Late mortality was defined as mortality due to any cause at longitudinal follow-up.
Surgical technique
Conventional cardiopulmonary bypass with mild hypothermia was performed with a single aortic cross-clamp technique. Among the matched cohorts, the LAD was bypassed with a free LIMA in 94.1% of cases for the f-IMA group and an in situ LIMA in 99.2% of cases for the is-IMA group; in the remaining matched patients the LAD was bypassed by the free and in situ right IMA, respectively. Patients receiving RIMA to LAD grafts, a small minority in each group, were included as existing literature suggests similar clinical outcomes with this strategy [12, 13] . The reasons for using an f-IMA were extracted from the surgeon's operative report: significant stenosis of the left subclavian artery (n = 96), proximal LIMA injury at harvesting (n = 61), distal LIMA injury (n = 52), and inadequate length of the in situ LIMA pedicle to reach the target due to extensive proximal disease on the LAD (n = 29). Significant left subclavian artery stenosis had been suggested by either a Doppler ultrasound examination of supraaortic vessels in patients with severe peripheral vascular disease, or a history of thoracic left-sided radiation, or in the presence of a significant blood pressure difference between the patient's 2 arms measured by non-invasive methods before arterial line insertion. Measurement of the bilateral upper extremity noninvasive cuff arterial blood pressures is a routine practice by the anaesthesiology department of our centre before insertion of the arterial line. A systolic pressure gradient of 40 mmHg between the 2 upper extremities is the subjective cut-off used at our institution prompting the use of the IMA as a free graft. A single distal anastomosis was performed with the IMA to bypass the LAD in all cases in both groups. The proximal anastomosis of the f-IMA was performed either on the ascending aorta after performing a small circular aortotomy with a 3.0 or 3.5 mm aortic punch (n = 117), or to a saphenous vein hood (n = 121), based on individual surgeon preference.
Statistical analysis
A continuous propensity score analysis was performed to adjust for the inter-group clinical differences caused by the selection bias inherent to the non-randomized nature of this study. Propensity scores representing the likelihood of receiving an f-IMA was calculated for each patient by the use of a logistic regression analysis. The variables included in the logistic regression analysis were closely related to both the choice of treatment (f-IMA) and the effect of the treatment: age, sex, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, urgent procedure, left ventricular ejection fraction, peripheral arterial disease, clinical indication for coronary revascularization (stable angina pectoris versus acute coronary syndrome), creatinine level, renal failure, left main stenosis and prior myocardial infarction. Continuous variables were checked for the assumption of linearity in the logit and the graphical representations suggested linear relationships. The variables were selected only if they maximized the within sample correct prediction rates. Interactions between variables were allowed only if it was supported clinically and statistically (P < 0.20). After model building, to assess the goodness-of-fit of the model, the Hosmer-Lemeshow test was performed, resulting with a v 2 = 2.27 with 8 degrees of freedom and P = 0.9716, indicating that the final model fitted quite well. On estimation of the propensity score, subjects with f-IMA were matched 1:1 to subjects in the is-IMA group. Matched sets on the propensity score with replacement were performed using the greedy matching algorithm. This approach matches patients on decreasing levels of precision on their propensity score. Each f-IMA subject was matched to an is-IMA subject whose score equals to at least the sixth digit. Patients with valid provincial health insurance numbers that could be subsequently linked to the government hospital readmission database were available for matching (n = 222 of all f-IMA patients during the study period). When all matches at the sixth digit were exhausted (178 of 222 f-IMA subjects), the process was begun again at the fifth digit and so forth (22 of 44 f-IMA not matched previously). This process was repeated until matches were completed on the 3 digits of the propensity score. This matching algorithm and subsequent propensity score analysis were consistent with recently published guidelines [14] .
Using this algorithm, many patients in the f-IMA subgroup could be matched to more than 1 candidate from the control group of is-IMA patients. Rather than report results from only 1 random sample of 222 pairs of subjects with may introduce bias, we preferred to resample the study population 1000 times in order to reflect the many possible matched pairs and therefore reduce the bias of the statistic of interest. Our statistic of interest was the 'mean' and the bootstrap distribution obtained for this statistic after 1000 samplings with replacement. For continuous variables, the statistic represents the sampling distribution of the 'mean differences' between groups with its 95% confidence interval (CI). For dichotomous variables, the odds ratio (OR) estimates are computed from the exponential of the mean and its 95% CI of the 1000 estimates from stratified logistic regression as data were paired on propensity score. For variables expressed as event-free at follow-up, the hazard ratio are derived from the exponential of the mean and its 95% CI of the 1000 estimates from conditional Cox proportional random effects regression analyses appropriate for paired data on propensity score. For all variables, according to the central limit theorem, the shape of the sampling distribution from the bootstraps was nearly normal. Statistical significance was considered present when the 95% CI around the OR or hazard ratio estimates did not include unity (or zero for continuous variables). Graphical representation of event-free survival at follow-up is from a Cox regression analysis adjusted for propensity score. To report the mean follow-up, the Efron's tail correction was used as the observation with the longest followup was censored. Analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). Our institutional ethics board granted the study full approval. Individual patient consent was waived due to the retrospective nature of the data and the fact that individual patient identifiers were stripped during linkage to vital statistics and rehospitalization data.
RESULTS
Baseline characteristics and early outcomes
Baseline clinical characteristics of the unmatched and matched patients are shown in Tables 1 and 2 , respectively. The preoperative variables were not significantly different among the patients in the 2 matched groups. Mean logistic EuroSCORE and Parsonnet score were similar in the matched groups (3.9 ± 0.03 vs 3.9 ± 0.20 and 2.2 ± 0.01 vs 2.2 ± 0.15 for f-IMA versus is-IMA patients, respectively). However, there was a slightly higher prevalence of a history of stroke and peripheral vascular disease in the matched f-IMA subgroup, which remained statistically significant despite risk adjustment.
Intraoperative characteristics of the 2 cohorts are reported in Table 3 . Cardiopulmonary bypass time was significantly higher in the f-IMA group by an average of approximately 14 min. However, the number of distal anastomoses was similar in both groups. Hospital mortality was slightly higher among the matched patients who underwent f-IMA grafting although this was not statistically significant (3.2% f-IMA vs 1.9% is-IMA; OR = 1.79, 95% CI = 0.91-3.52). Among the matched patients, the causes of early mortality were mostly cardiac (47.4% vs 52.6% for f-IMA versus is-IMA patients, respectively). The non-cardiac causes of early mortality were neurologic (15.6% vs 11.6% for f-IMA versus is-IMA patients, respectively), respiratory (19.8% vs 26.3% for f-IMA versus is-IMA patients, respectively) and infectious (15.6% vs 9% for f-IMA versus is-IMA patients, respectively). Postoperative adverse events were largely similar between the 2 matched cohorts (Table 4) . However, we observed higher rates of pulmonary infection (6.8% vs 4.5%; OR = 1.56, 95% CI = 1.05-2.31), blood product transfusion (59.0% vs 49.0%; OR = 1.50, 95% CI = 1.22-1.86) and de novo renal failure (14.4% vs 10.3%; OR = 1.53, 95% CI = 1.07-2.19) in the f-IMA group compared to the is-IMA group, respectively.
Long-term outcomes
Mean overall follow-up was 9.5 ± 5.6 years (median 9 years; interquartile range, 4.6-13.3 years; maximum 23 years), and was not significantly different between matched f-IMA and is-IMA groups. Five-, 10-and 15-year survival were 86.7%, 71.2% and 
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53.7% in the f-IMA group, and 91.4%, 77.9% and 62.5% in the is-IMA group. In the final propensity analysis using bootstrapping, the risk of late death was not significantly different between the 2 matched groups (hazard ratio = 1.17, 95% CI = 0.95-1.39; P = 0.15) (Fig. 1) . However, the risk of late death was significantly higher among unmatched patients with f-IMA graft ( Fig. 2, P of readmission including neurologic and peripheral vascular were not statistically different between matched groups (9.5% in f-IMA vs 6.7% in is-IMA matched patients, OR = 1.47; 95% CI = 0.94-2.30).
DISCUSSION
The main finding of this study was that, when the IMA cannot be used in situ to bypass the LAD, the early and long-term outcomes of a free mammary graft on the LAD are comparable, even if the proximal connection to the subclavian artery is disrupted. To the best of our knowledge, this is the first study performed to answer the question: is it safe and effective to use the IMA as a free graft on the LAD, and are the long-term benefits of this procedure compromised if the IMA is proximally disconnected?
It has been 30 years since the superiority of the IMA graft over the saphenous vein graft has been demonstrated by Loop et al. [2] . As a consequence of this finding, the interest in the use of arterial conduits for coronary artery bypass has gradually increased and the LIMA to the LAD is nowadays one of the most solid certainties of cardiac surgery. Several studies have also explored the potential benefits of a strategy of bilateral IMA grafting [15] [16] [17] [18] [19] , and some authors support also the choice of alternative arterial grafts [20, 21] . The wider use of bilateral IMA has also increased the interest in the RIMA as a free graft, a safe and versatile surgical strategy that allows the surgeon to reach distal coronary targets [9] [10] [11] 22] . Several authors report that the RIMA can be safely used as a free graft, with short-and long-term clinical results that are similar to those obtained with the in situ LIMA [8] [9] [10] . Moreover, the group of Harefield has shown that the RIMA, Defined as a 50% rise in baseline serum creatinine level or new need for dialysis. d Mean differences from the propensity score bootstrap estimation. anastomosed as a free graft on any of the coronary arteries, functions in the same way as an in situ LIMA, with comparable endothelial-dependent and endothelial-independent vasodilatory mechanisms [11] . For these reasons, it is not difficult to conceive that the IMA, anastomosed as a free-graft to the LAD, should give the same excellent long-term results of an is-IMA. Over the years, this surgical option has been adopted in our institution when the in situ use of the IMA is not possible and technical circumstances are suitable.
Considering hospital mortality, rates were slightly higher among the matched patients who underwent f-IMA grafting, but the difference was not statistically significant. Early mortality was inferior to the predicted logistic EuroSCORE rate in both groups. It is important to mention that the study cohort includes patients who underwent CABG over a period of more than 20 years, during which there were dramatic advances in postoperative secondary prevention and atherosclerotic risk factor modification. Patients in the matched f-IMA group experienced higher rates of postoperative pulmonary infection, transfusions and renal failure. A possible explanation could be given by the longer CPB time, which is inevitably linked to the fact that in the case of f-IMA, it is necessary to make one more proximal anastomosis. Moreover, in our cohort, the f-IMA was used in patients with left subclavian stenosis and this could be a marker for more frequent peripheral vascular disease, which may also be associated with a number of adverse postoperative events such as renal failure and early mortality. However, higher rates of renal failure did not result in an increased use of postoperative dialysis, and pulmonary complications did not prolong intubation times, intensive care unit stay and total length of hospitalization.
In terms of long-term outcomes, we found that late survival was not adversely affected by taking the IMA down as a free graft to the LAD. However, there was a 7% absolute increased risk of hospital readmission for cardiovascular causes in the f-IMA group during the follow-up period, which was mainly driven by cardiac events. Despite this observation of a small but significantly higher risk of cardiovascular readmission in the matched f-IMA group, repeat coronary revascularization procedures, either percutaneous or surgical, were similar in the 2 matched groups. This could be explained by the presence of a higher atherosclerotic burden in the f-IMA group at baseline as evidenced by the fact that this group had a higher prevalence of previous stroke and peripheral vascular disease. These high-risk features present in the f-IMA group do not confer a survival disadvantage after risk adjustment using propensity scores. The group of Yale [10] reported similarly excellent results in terms of free-RIMA patency rates and longterm survival, comparable to the in situ LIMA and superior to those of saphenous vein grafts. Tatoulis et al. [9] showed that the late patency of the free-RIMA graft at 5 years was similar to that achieved with pedicled LIMA grafts, underlining that once a free-IMA graft is functioning beyond 12 months, it is very likely to remain patent in the long-term. These results, together with our data, confirm that the durability and effectiveness of a 'free-graft procedure' are equivalent to those of a traditional 'in situ setting', thus expanding the potential use of free-IMA grafts in CABG surgery. Despite that, it is necessary to highlight that after 10 years, our survival curves tend to move away from each other (Fig. 1) and there is patient attrition after many years of follow-up, which decreases our ability to make meaningful statements about the clinical effectiveness of the f-IMA to LAD graft at these late time points. A prolonged follow-up with many patients available for follow-up beyond 10 years post-CABG is needed for the free-IMA cases, in order to confirm the long-term durability of the graft.
Regarding the technical concerns about this surgical strategy, a key point may be the selection of the site of the proximal anastomosis of the f-IMA. Some authors showed excellent patency rate when the proximal end of the f-IMA is anastomosed to the hood of a vein graft instead of directly onto the aorta [22] . This latter option is in fact considered by some authors as technically more difficult, because of the mismatch between the thickness of the vascular walls of the aorta and the IMA. In our study, both surgical techniques were used almost equally, varying mainly according to surgeon preference. However, the subsequent loss of power inherent in further sub-stratifying the f-IMA cohort according to site of the proximal anastomosis does not allow us to make meaningful analyses regarding the association of site of proximal f-IMA anastomosis and outcome. Based on our experience, technical recommendations relating to the proximal anastomosis of the f-IMA on the ascending aorta are the following: a small aortotomy should be done with a 3.0 or 3.5 aortic punch, depending on the size of the IMA, in order to avoid splaying of the IMA graft at the aortic anastomosis and a 'seagull' deformity, and the anastomosis should be performed with a small-needled and caliber polypropylene suture.
Limitations
The main study limitation relates to its retrospective/observational design, with its inherent bias. Another important limitation is related to the fact that the surgical strategy, and especially the type of proximal anastomosis of the f-IMA, is determined by individual surgeon preference. We have not included patients in which the IMA was damaged and was ultimately not used, but this was not the objective of the study as it is well known that a saphenous vein graft to the LAD is associated with a patency disadvantage. The absence of late graft patency data is another limitation of the study. Computed tomography angiography and/or coronary catheterization were not routinely performed as this was a retrospective study. The use of provincial administrative rehospitalization data functions as a reasonable surrogate for cardiac events in this population and mortality and hospital readmission for adverse cardiac events are 'hard' and relevant clinical end-points. If there was a true clinically significant patency disadvantage associated with an f-IMA, this should translate to a significantly increased rate of cardiac ischaemic events requiring intervention (surgery or percutaneous coronary intervention) and/or mortality, which was not observed in our study. This is all the more true given the primordial importance of the f-IMA to LAD graft given the prognostic significance of the territory grafted (i.e. the anterior wall). Unmeasured variables due to the fact that the study comprises a long period of 23 years may also introduce some bias, such as the evolution of surgical technique of IMA harvesting over time, graft preparation and anastomotic techniques, as well as varying medical management for secondary prevention of atherosclerotic risk factors. However, these variables are expected to be evenly distributed between the 2 groups of interest in this study and are not likely to favour 1 group over another. Moreover, the longitudinal data which captures community-acquired cardiovascular end-points to a maximum of 23 years with low rates of loss-to-follow-up is a definite strength of this study.
CONCLUSION
Survival following CABG does not seem to be negatively influenced by using the IMA as a free graft to bypass the LAD. The long-term survival benefit associated with the standard in situ LIMA to LAD graft is not compromised when the proximal connection of the LIMA to the subclavian artery is disrupted. When the LIMA pedicle cannot be anastomosed in situ to the LAD, the use of an f-IMA graft should be encouraged.
